Inactivation des pathogènes des produits sanguins labiles: entre enjeux financiers et conséquences possibles à long terme [Pathogen reduction of blood components: from financial issues to possible long-term consequences].

Détails

ID Serval
serval:BIB_540097E98FF2
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Inactivation des pathogènes des produits sanguins labiles: entre enjeux financiers et conséquences possibles à long terme [Pathogen reduction of blood components: from financial issues to possible long-term consequences].
Périodique
Transfusion Clinique et Biologique
Auteur(s)
Canellini G., Wasserfallen J.B., Tissot J.D.
ISSN
1953-8022 (Electronic)
ISSN-L
1246-7820
Statut éditorial
Publié
Date de publication
2011
Peer-reviewed
Oui
Volume
18
Numéro
4
Pages
493-497
Langue
français
Notes
Publication types: English Abstract ; Journal Article ; Review
Publication Status: ppublish
Résumé
Pathogen inactivation of blood products represents a global and major paradigm shift in transfusion medicine. In the next near future, it is likely that most blood products will be inactivated by various physicochemical approaches. The concept of blood safety will be challenged as well as transfusion medicine practice, notably for donor selection or biological qualification. In this context, it seems mandatory to develop analytical economic approaches by assessing costs-benefits ratio of blood transfusion as well as to set up cohorts of patients based on hemovigilance networks allowing rigorous scientific analysis of the benefits and the risks of blood transfusion at short- and long-term.
Mots-clé
Blood Component Transfusion/adverse effects, Blood-Borne Pathogens, Humans, Infection Control/economics, Infection Control/methods
Pubmed
Web of science
Création de la notice
08/09/2011 21:23
Dernière modification de la notice
20/08/2019 15:09
Données d'usage